Late Neutropenia in VLBW Preterm Babies

Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04217811
Collaborator
(none)
237
1
24
9.9

Study Details

Study Description

Brief Summary

There are rare reports regarding late neutropenua in very low birth weight preterm infants.

The investigators wish to characterize it among our population, and assess its consequenses and the postnatal menagement of the infants.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

There are rare reports regarding late neutropenua in very low birth weight preterm infants.

The investigators wish to characterize it among our population, and assess its consequenses and the postnatal menagement of the infants.

Study Design

Study Type:
Observational
Actual Enrollment :
237 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Late Neutropenia in VLBW Preterm Babies - Characterization and Post Natal Menagement
Actual Study Start Date :
Jan 1, 2020
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Late neutropenia

Neutrophil count < 1500

Other: No intervention
No intervention

No late neutropenia

Neutrophil count > 1500

Other: No intervention
No intervention

Outcome Measures

Primary Outcome Measures

  1. Length of stay [2 weeks]

    Number of days

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 30 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Preterm infant with birth weight up to 1500 gram
Exclusion Criteria:
  • Early neutroenia - neutrophil count < 1500 at the first week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hillel Yaffe medical center H̀±adera Hadera Israel 38100

Sponsors and Collaborators

  • Hillel Yaffe Medical Center

Investigators

  • Principal Investigator: Erez Nadir, MD, Hillel Yaffe Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Erez Nadir, MD, Principal investigator, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT04217811
Other Study ID Numbers:
  • 0160-19-HYMC
First Posted:
Jan 3, 2020
Last Update Posted:
Aug 18, 2022
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Erez Nadir, MD, Principal investigator, Hillel Yaffe Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2022